FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002309130> ?p ?o ?g. }

• W2002309130 endingPage "53" @default.
• W2002309130 startingPage "41" @default.
• W2002309130 abstract "Capillary formation has been correlated with changes in basement membrane-associated glycosaminoglycans (GAGs).1 During capillary growth when endothelial cells (EC) undergo extensive proliferation and migration and pericytes are scarce, hyaluronic acid (HA) levels are elevated. Upon capillary maturation when EC migration and proliferation cease and pericytes appear, the dominant GAG is heparan sulfate (HS). To investigate the potential role of GAGs in the angiogenic process, we studied the effect of HA, heparin, chondroitin sulfate, and dermatan sulfate on the attachment and proliferation of vascular wall cells in vitro. Cell attachment was studied by determining the number of cells attached to GAG-treated substrates. Whereas HA inhibited the attachment of both pericytes and smooth muscle cells (SMC) by nearly 80% after 8 hr, it enhanced capillary EC attachment by more than 30%. Retinal pigment epithelial cells and dermal fibroblasts were employed as controls and none of the GAGs examined significantly altered the attachment of these cells. The effect of GAGs on cell proliferation was determined by the addition of soluble GAGs to cells cultured for the time required for three population doublings. Heparin addition resulted in a dose-dependent inhibition of both pericyte and SMC proliferation with maximal inhibition of 50% at 100 μg/ml, whereas this concentration of heparin moderately enhanced capillary EC proliferation. These effects were not observed for any other cell type or with any other GAG and indicate that GAGs have cell-specific effects on the attachment and proliferation of cells of the vascular wall." @default.
• W2002309130 created "2016-06-24" @default.
• W2002309130 creator A5017563993 @default.
• W2002309130 creator A5041333488 @default.
• W2002309130 date "1986-01-01" @default.
• W2002309130 modified "2023-10-18" @default.
• W2002309130 title "Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components" @default.
• W2002309130 cites W1503794954 @default.
• W2002309130 cites W1508769459 @default.
• W2002309130 cites W1524830639 @default.
• W2002309130 cites W1534818109 @default.
• W2002309130 cites W1628719417 @default.
• W2002309130 cites W1806064940 @default.
• W2002309130 cites W1964492287 @default.
• W2002309130 cites W1964537647 @default.
• W2002309130 cites W1965769658 @default.
• W2002309130 cites W1966171513 @default.
• W2002309130 cites W1973418971 @default.
• W2002309130 cites W1976030535 @default.
• W2002309130 cites W1977647836 @default.
• W2002309130 cites W1977798903 @default.
• W2002309130 cites W1986410705 @default.
• W2002309130 cites W1988965035 @default.
• W2002309130 cites W1993582348 @default.
• W2002309130 cites W1994887403 @default.
• W2002309130 cites W1998775261 @default.
• W2002309130 cites W2000777523 @default.
• W2002309130 cites W2005834510 @default.
• W2002309130 cites W2006482338 @default.
• W2002309130 cites W2011915218 @default.
• W2002309130 cites W2022502270 @default.
• W2002309130 cites W2037012329 @default.
• W2002309130 cites W2037863870 @default.
• W2002309130 cites W2052746935 @default.
• W2002309130 cites W2053474589 @default.
• W2002309130 cites W2055366835 @default.
• W2002309130 cites W2061518584 @default.
• W2002309130 cites W2062075300 @default.
• W2002309130 cites W2067836725 @default.
• W2002309130 cites W2070354787 @default.
• W2002309130 cites W2072987324 @default.
• W2002309130 cites W2076489015 @default.
• W2002309130 cites W2081887194 @default.
• W2002309130 cites W2082688835 @default.
• W2002309130 cites W2085216816 @default.
• W2002309130 cites W2093289536 @default.
• W2002309130 cites W2103669145 @default.
• W2002309130 cites W2125258660 @default.
• W2002309130 cites W2141905517 @default.
• W2002309130 cites W2143691192 @default.
• W2002309130 cites W2148097744 @default.
• W2002309130 cites W2306845595 @default.
• W2002309130 cites W2407762208 @default.
• W2002309130 cites W2414465054 @default.
• W2002309130 cites W4213075020 @default.
• W2002309130 doi "https://doi.org/10.1016/0026-2862(86)90005-1" @default.
• W2002309130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3959914" @default.
• W2002309130 hasPublicationYear "1986" @default.
• W2002309130 type Work @default.
• W2002309130 sameAs 2002309130 @default.
• W2002309130 citedByCount "67" @default.
• W2002309130 countsByYear W20023091302012 @default.
• W2002309130 countsByYear W20023091302013 @default.
• W2002309130 countsByYear W20023091302014 @default.
• W2002309130 countsByYear W20023091302016 @default.
• W2002309130 countsByYear W20023091302020 @default.
• W2002309130 crossrefType "journal-article" @default.
• W2002309130 hasAuthorship W2002309130A5017563993 @default.
• W2002309130 hasAuthorship W2002309130A5041333488 @default.
• W2002309130 hasConcept C105702510 @default.
• W2002309130 hasConcept C123012128 @default.
• W2002309130 hasConcept C1491633281 @default.
• W2002309130 hasConcept C153074725 @default.
• W2002309130 hasConcept C185592680 @default.
• W2002309130 hasConcept C202751555 @default.
• W2002309130 hasConcept C2777529286 @default.
• W2002309130 hasConcept C2777557582 @default.
• W2002309130 hasConcept C2778041096 @default.
• W2002309130 hasConcept C2778066728 @default.
• W2002309130 hasConcept C2779553658 @default.
• W2002309130 hasConcept C2780427682 @default.
• W2002309130 hasConcept C2908647359 @default.
• W2002309130 hasConcept C55493867 @default.
• W2002309130 hasConcept C62112901 @default.
• W2002309130 hasConcept C71924100 @default.
• W2002309130 hasConcept C86803240 @default.
• W2002309130 hasConcept C95444343 @default.
• W2002309130 hasConcept C99454951 @default.
• W2002309130 hasConceptScore W2002309130C105702510 @default.
• W2002309130 hasConceptScore W2002309130C123012128 @default.
• W2002309130 hasConceptScore W2002309130C1491633281 @default.
• W2002309130 hasConceptScore W2002309130C153074725 @default.
• W2002309130 hasConceptScore W2002309130C185592680 @default.
• W2002309130 hasConceptScore W2002309130C202751555 @default.
• W2002309130 hasConceptScore W2002309130C2777529286 @default.
• W2002309130 hasConceptScore W2002309130C2777557582 @default.
• W2002309130 hasConceptScore W2002309130C2778041096 @default.
• W2002309130 hasConceptScore W2002309130C2778066728 @default.

• next